241 related articles for article (PubMed ID: 32712273)
21. N-acetylaspartylglutamate (NAAG) inhibits intravenous cocaine self-administration and cocaine-enhanced brain-stimulation reward in rats.
Xi ZX; Kiyatkin M; Li X; Peng XQ; Wiggins A; Spiller K; Li J; Gardner EL
Neuropharmacology; 2010 Jan; 58(1):304-13. PubMed ID: 19559037
[TBL] [Abstract][Full Text] [Related]
22. The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats.
Adamczyk P; Miszkiel J; McCreary AC; Filip M; Papp M; Przegaliński E
Brain Res; 2012 Mar; 1444():45-54. PubMed ID: 22325096
[TBL] [Abstract][Full Text] [Related]
23. The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic.
Zhang HY; Bi GH; Yang HJ; He Y; Xue G; Cao J; Tanda G; Gardner EL; Newman AH; Xi ZX
Neuropsychopharmacology; 2017 Aug; 42(9):1871-1883. PubMed ID: 28266501
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological regulation of cannabinoid CB2 receptor modulates the reinforcing and motivational actions of ethanol.
Navarrete F; García-Gutiérrez MS; Manzanares J
Biochem Pharmacol; 2018 Nov; 157():227-234. PubMed ID: 30063884
[TBL] [Abstract][Full Text] [Related]
25. The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.
Xi ZX; Newman AH; Gilbert JG; Pak AC; Peng XQ; Ashby CR; Gitajn L; Gardner EL
Neuropsychopharmacology; 2006 Jul; 31(7):1393-405. PubMed ID: 16205781
[TBL] [Abstract][Full Text] [Related]
26. β-Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents.
He Y; Galaj E; Bi GH; Wang XF; Gardner E; Xi ZX
Br J Pharmacol; 2020 May; 177(9):2058-2072. PubMed ID: 31883107
[TBL] [Abstract][Full Text] [Related]
27. Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats.
Fujii M; Sherchan P; Krafft PR; Rolland WB; Soejima Y; Zhang JH
J Neurol Sci; 2014 Jul; 342(1-2):101-6. PubMed ID: 24819918
[TBL] [Abstract][Full Text] [Related]
28. Effects of Cocaine Self-Administration and Its Extinction on the Rat Brain Cannabinoid CB1 and CB2 Receptors.
Bystrowska B; Frankowska M; Smaga I; Pomierny-Chamioło L; Filip M
Neurotox Res; 2018 Oct; 34(3):547-558. PubMed ID: 29754307
[TBL] [Abstract][Full Text] [Related]
29. Cannabinoid CB
Li AL; Carey LM; Mackie K; Hohmann AG
J Pharmacol Exp Ther; 2017 Aug; 362(2):296-305. PubMed ID: 28592614
[TBL] [Abstract][Full Text] [Related]
30. Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague-Dawley Rats.
Calik MW; Carley DW
Sleep; 2017 Sep; 40(9):. PubMed ID: 28934522
[TBL] [Abstract][Full Text] [Related]
31. Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis.
Porter RF; Szczesniak AM; Toguri JT; Gebremeskel S; Johnston B; Lehmann C; Fingerle J; Rothenhäusler B; Perret C; Rogers-Evans M; Kimbara A; Nettekoven M; Guba W; Grether U; Ullmer C; Kelly MEM
Molecules; 2019 Sep; 24(18):. PubMed ID: 31540271
[TBL] [Abstract][Full Text] [Related]
32. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice.
Sørensen G; Reddy IA; Weikop P; Graham DL; Stanwood GD; Wortwein G; Galli A; Fink-Jensen A
Physiol Behav; 2015 Oct; 149():262-8. PubMed ID: 26072178
[TBL] [Abstract][Full Text] [Related]
33. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
[TBL] [Abstract][Full Text] [Related]
34. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
Davis MP
Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents.
Shearman LP; Stribling DS; Camacho RE; Rosko KM; Wang J; Tong S; Feng Y; Marsh DJ; Yu H; Guan X; Spann SK; Macneil DJ; Fong TM; Metzger JM; Goulet MT; Hagmann WK; Plummer CW; Finke PE; Mills SG; Shah SK; Truong Q; Van der Ploeg LH; Macintyre DE; Strack AM
Eur J Pharmacol; 2008 Jan; 579(1-3):215-24. PubMed ID: 18021763
[TBL] [Abstract][Full Text] [Related]
36. Levo-tetrahydropalmatine inhibits cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.
Xi ZX; Yang Z; Li SJ; Li X; Dillon C; Peng XQ; Spiller K; Gardner EL
Neuropharmacology; 2007 Nov; 53(6):771-82. PubMed ID: 17888459
[TBL] [Abstract][Full Text] [Related]
37. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
Thomas A; Baillie GL; Phillips AM; Razdan RK; Ross RA; Pertwee RG
Br J Pharmacol; 2007 Mar; 150(5):613-23. PubMed ID: 17245363
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018.
Gamage TF; Barrus DG; Kevin RC; Finlay DB; Lefever TW; Patel PR; Grabenauer MA; Glass M; McGregor IS; Wiley JL; Thomas BF
Pharmacol Biochem Behav; 2020 Jun; 193():172918. PubMed ID: 32247816
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of cannabinoid ligand-induced modulations in intracellular Ca
Xia KK; Shen JX; Huang ZB; Song HM; Gao M; Chen DJ; Zhang SJ; Wu J
Acta Pharmacol Sin; 2019 Mar; 40(3):410-417. PubMed ID: 30202013
[TBL] [Abstract][Full Text] [Related]
40. Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents.
Álvaro-Bartolomé M; García-Sevilla JA
Neuroscience; 2013 Sep; 247():294-308. PubMed ID: 23727505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
